On April 28, 2009, the Institute of Medicine (IOM) issued a report endorsing new voluntary and regulatory measures to strengthen protections against financial conflicts of interest in medicine. The report addresses conflicts of interest in a number of settings, including biomedical research, clinical care, physician training, and continuing medical education. Among other things, the IOM recommends improving disclosure of financial ties between the medical community and the pharmaceutical, biotechnology, and medical device industry; limiting company payments and gifts; stemming industry influence in medical education and the development of practice guidelines; and adopting safeguards pertaining to consulting arrangements.
- How-to guide How-to guide: How to manage your organization’s data privacy and security risks (USA)
- How-to guide How-to guide: How to understand and comply with wage and hour laws (USA)
- How-to guide How-to guide: How to comply with due diligence requirements for financial institutions determined to be of primary money laundering concern (USA)